advertisement

Wednesday, November 25, 2009
[an error occurred while processing this directive]

Estrogen preparations

A synthetic form of the female hormone estrogen can lower testosterone levels to the castrate range by blocking the release of luteinizing hormone from the pituitary gland, thereby shutting down the production of testosterone. Daily doses of synthetic estrogen (Premarin) are as effective as surgical castration, though the hormone takes longer to work; testosterone levels fall over a two-week period.

Multimedia

Health Tips from Dr. Healy:
Video: Why cancer patients should stop smoking

Related Links
Bullet Eight steps you can take to reduce your risk of cancer
Bullet Interested in a clinical trial? Here's all you need to know
Bullet See the top online resources for prostate cancer information
Bullet How to lose weight and keep it off
Bullet Prostate Cancer-Related Clinical Trials Information
0
Email this sectionEmail this pagePrint this sectionPrint this section
0
0
0

The most significant side effect of synthetic estrogen is an increased risk of cardiovascular complications. These include heart attack, stroke, blood clots in the lungs or legs, phlebitis (inflammation of the veins) and edema (swelling of the legs). Because of these risks, people with a history of heart disease or thrombophlebitis (vein inflammation due to a blood clot) should not use estrogen therapy. In other people, these side effects can be minimized by using low doses of estrogen. In addition, taking an aspirin every other day helps to lower the risk of heart attach and blood clots; edema can be treated with diuretics (drugs that promote water loss through urine). Estrogen can also cause nausea and vomiting. And, like surgical castration, estrogen can cause breast enlargement and erectile dysfunction.

With the approval of LH-RH analogs, estrogens are no longer widely used. However, there is renewed interest in diethylstilbestrol (DES), a form of estrogen used in the 1960s for advanced prostate cancer. In addition, researchers are investigating the potential of an estrogen patch to lower testosterone levels without the side effects associated with other types of hormone therapy.

Content last updated: 8/15/05Previous PagePrevious page Next PageNext Page



Content excerpted from the Johns Hopkins White Paper on Prostate Disorders.




U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.

advertisement

advertisement

advertisement


Copyright © 2007 U.S.News & World Report, L.P. All rights reserved.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.